Results 31 to 40 of about 13,503 (207)

Ulcerative proctitis: an update on the pharmacotherapy and management. [PDF]

open access: yes, 2014
Introduction: Ulcerative colitis (UC) presents as proctitis in approximately a quarter of the patients. It may progress into left-sided or extensive colitis in up to 50% of cases upon long-term follow-up.Areas covered: Currently available data on ...
Gecse, Krisztina   +1 more
core   +1 more source

Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease

open access: yesScientific Reports, 2020
Mesalazine is a key drug used for remission induction and maintenance therapy in inflammatory bowel disease (IBD). We sometimes encounter patients who develop allergic reactions to the drug and inevitably discontinue treatment.
Satohiro Matsumoto, Hirosato Mashima
doaj   +1 more source

Mesalazine-induced Hypersensitivity Pneumonitis

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2021
A 57-year-old woman with Crohn's disease (ulcerative proctitis) treated with mesalazine (5-ASA) developed worsening respiratory distress and cough. The lack of response to antibiotics and the results of bronchoalveolar lavage led to the diagnosis of ...
Ana Pereira   +6 more
doaj   +1 more source

Drugs for the treatment of ulcerative colitis on the pharmaceutical market of Ukraine

open access: yesФармацевтичний журнал, 2023
The prevalence of diseases of the digestive organs at the current stage of human development is extremely high, and their universally increasing incidence rate is estimated as an epidemic. In Ukraine, mortality from diseases of the digestive organs ranks
L. M. Palchak   +2 more
doaj   +1 more source

The long-term effects of probiotics in the therapy of ulcerative colitis: a clinical study [PDF]

open access: yes, 2016
Aim. Intestinal dysbiosis seems to be the leading cause of inflammatory bowel diseases, and probiotics seems to represent the proper support against their occurrence.
Buscemi, S   +10 more
core   +1 more source

Recurrent Interstitial Pneumonitis in a Patient with Entero-Behçet’s Disease Initially Treated with Mesalazine

open access: yesCase Reports in Rheumatology, 2016
A 65-year-old man with entero-Behçet’s disease (BD) being treated with mesalazine was presented to our hospital complaining of dyspnea. Computed tomography (CT) of the chest showed ground-glass opacities and he was initially diagnosed with mesalazine ...
Akihiro Nakamura   +3 more
doaj   +1 more source

Severe Gastroduodenitis Associated With Ulcerative Colitis After Total Colectomy Successfully Treated With Endoscopic Hemostasis and Oral Tacrolimus. [PDF]

open access: yesDEN Open
ABSTRACT Herein, we report a rare case of gastroduodenitis associated with ulcerative colitis (UC). A 42‐year‐old man was diagnosed with UC 1 year prior to admission to our hospital. The patient underwent a 3‐stage total colectomy and ileal pouch‐anal anastomosis for severe UC.
Fujimoto K   +6 more
europepmc   +2 more sources

Acute Pancreatitis due to pH-Dependent Mesalazine That Occurred in the Course of Ulcerative Colitis

open access: yesCase Reports in Gastroenterology, 2011
We report the case of a 26-year-old male who presented with acute pancreatitis during the course of treatment for pancolitic ulcerative colitis (UC) with a time-dependent mesalazine formulation, prednisolone and azathioprine (AZA).
Yoshinori Arai   +11 more
doaj   +1 more source

THE ROLE OF BUTYRIC ACID AS A OPROTECTIVE AGENT AGAINST INFLAMMATORY BOWEL DISEASE [PDF]

open access: yes, 2014
Inflammatory Bowel disease (IBD), such as Crohn's disease and ulcerative colitis, are pathologies characterized by a chronic inflammation of the gastrointestinal tract. Their etiopathogenesis is not yet fully understood.
ABRUZZO, Alida   +14 more
core   +1 more source

Pharmacokinetic and safety profiles of mesalazine enema in healthy Chinese subjects: A single- and multiple-dose study.

open access: yesPLoS ONE
Mesalazine is a well-established treatment for ulcerative colitis by oral or topical administration. However, the pharmacokinetic (PK) and safety profiles of mesalazine administered by an enema has not been clarified in Chinese population.
Yuran Cao   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy